Head and Neck Cancer Trial, Recruiting NCT03829033 Sponsor: Lund University Hospital Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT03829033
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are at least 18 years old
  • People who have been diagnosed with a specific type of cancer called squamous cell carcinoma of the tonsil, confirmed by a tissue or cell sample, that has not been treated before, and is at an early to intermediate stage (as classified by a standard staging system called AJCC 8th edition)
  • People whose cancer is planned to be treated with radiation therapy alone, directed to one side of the body, with the goal of curing the cancer — any surgery would only happen afterward if needed, not as part of the planned treatment (a previous removal of a lymph node or tonsil for diagnostic purposes does not disqualify someone)
  • People who are generally well and able to carry out daily activities with little to no limitation (rated 0 or 1 on a standard health performance scale)
  • People who are able to understand information about the treatment and provide written consent to participate

Who may not be able to join:

  • People whose treating doctor judges that they would benefit more from radiation directed to both sides of the neck, or from receiving chemotherapy at the same time as radiation
  • People who have, or have previously had, another cancer — with exceptions for certain treated skin cancers or cervical pre-cancers with at least 3 years of follow-up, or other previous cancers with at least 5 years free of disease
  • People who have two or more separate primary cancers in the head and neck area at the time of diagnosis
  • People who have had previous surgery or radiation treatment to the head and neck area that the trial investigator believes could affect the study results
  • People with another serious illness that is expected to affect survival within the next 2 years
  • People with psychiatric conditions, addiction disorders, or other medical conditions that the investigator believes may affect their ability to follow the trial requirements
  • People who have metal or amalgam dental fillings close to the tumour area, if the trial investigator determines this could interfere with radiation treatment (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maria Gebre-Medhin, MD, Lund University Hospiyal

Phone: +46 46 17 75 20

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Lund University Hospital
Registry
ClinicalTrials.gov
Start date
22 January 2019
Est. completion
1 January 2028

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Acute side effects.; Late side effects.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov